Adeniran Samuel Atiba
Adeniran Samuel Atiba publishes mostly in Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Endocrinology, Diabetes and Metabolism, on topics such as Pregnancy and preeclampsia studies, Gestational Diabetes Research and Management and Birth, Development, and Health.
- World rank
- #4,718,144 of 7,710,434 ranked researchers
- Rank in Nigeria
- #9,932 of 26,141
- Works
- 21
- Citations
- 187
- Citations per work
- 8.9
What does Adeniran Samuel Atiba research?
Adeniran Samuel Atiba's work is mostly in Medicine (65%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1465.0%
- Medicine1465.0%
- Everything else735.0%
- 1Obstetrics and Gynecology28% of their works
- 2Pediatrics, Perinatology and Child Health14% of their works
- 3Endocrinology, Diabetes and Metabolism7% of their works
- 4Emergency Medicine5% of their works
- 5Epidemiology5% of their works
- 6Pulmonary and Respiratory Medicine5% of their works
Research topics
- Pregnancy and preeclampsia studies
- Gestational Diabetes Research and Management
- Birth, Development, and Health
- HIV-related health complications and treatments
- Antioxidant Activity and Oxidative Stress
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer Research and Treatment
- Moringa oleifera research and applications
Which keywords describe Adeniran Samuel Atiba's research?
The keywords of their largest research topics: Metabolic Syndrome, Oxidative Stress, Placental Development, Preeclampsia, Gestational Diabetes Mellitus, Maternal Obesity, Cardiovascular Disease and Early-Life Conditions.
- Antioxidant Properties
- Nanoparticles
- Diabetes
- Antioxidants
- Antiretroviral Therapy
- Inflammation
- Early-Life Conditions
- Maternal Obesity
- Preeclampsia
- Oxidative Stress
- Metabolic Syndrome
- Placental Development
- Gestational Diabetes Mellitus
- Cardiovascular Disease
- Fetal Programming
- Atherosclerosis
- HIV Infection
- Cancer Cells
- Lipid Peroxidation
- Obesity
- Moringa oleifera
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Metabolic Syndrome133 topics
- Oxidative Stress122 topics
- Placental Development101 topic
- Preeclampsia101 topic
- Gestational Diabetes Mellitus61 topic
- Maternal Obesity61 topic
- Cardiovascular Disease52 topics
- Early-Life Conditions51 topic
- Fetal Programming51 topic
- Inflammation52 topics
- Atherosclerosis42 topics
- Antiretroviral Therapy31 topic
- HIV Infection31 topic
- Antioxidants21 topic
- Cancer Cells21 topic
- Diabetes21 topic
- Lipid Peroxidation21 topic
- Nanoparticles21 topic
- Obesity21 topic
- Antioxidant Properties11 topic
- Moringa oleifera11 topic
Where does Adeniran Samuel Atiba work?
Adeniran Samuel Atiba's main affiliation in the publication record is Ekiti State University, Nigeria.
How many publications and citations does Adeniran Samuel Atiba have?
OpenAlex counts 21 works and 187 citations for Adeniran Samuel Atiba, an h-index of 7, ranking #4,718,144 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Adeniran Samuel Atiba. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.